While differences in the tumor-suppressive and pro-carcinogenic properties of different p53 mutant proteins are recognized, our work provides a first example to highlight that distinct molecular mechanisms underlie the effects of domain-specific mutants, and can be used to differentiate cancers carrying them. The gene discussed is TP53; the disease is neoplasm.